These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3664998)

  • 1. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.
    Olafsson B; Forman MB; Puett DW; Pou A; Cates CU; Friesinger GC; Virmani R
    Circulation; 1987 Nov; 76(5):1135-45. PubMed ID: 3664998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.
    Babbitt DG; Virmani R; Forman MB
    Circulation; 1989 Nov; 80(5):1388-99. PubMed ID: 2805274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.
    Pitarys CJ; Virmani R; Vildibill HD; Jackson EK; Forman MB
    Circulation; 1991 Jan; 83(1):237-47. PubMed ID: 1984882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary adenosine administration during reperfusion following 3 hours of ischemia: effects on infarct size, ventricular function, and regional myocardial blood flow.
    Babbitt DG; Virmani R; Vildibill HD; Norton ED; Forman MB
    Am Heart J; 1990 Oct; 120(4):808-18. PubMed ID: 2220534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: effect of intracoronary adenosine.
    Velasco CE; Turner M; Cobb MA; Virmani R; Forman MB
    Am Heart J; 1991 Dec; 122(6):1561-70. PubMed ID: 1957750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion.
    Nichols WW; Nicolini FA; Yang BC; Henson K; Stechmiller JK; Mehta JL
    Am Heart J; 1994 May; 127(5):1201-11. PubMed ID: 8172047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
    Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
    Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion.
    Forman MB; Bingham S; Kopelman HA; Wehr C; Sandler MP; Kolodgie F; Vaughn WK; Friesinger GC; Virmani R
    Circulation; 1985 May; 71(5):1060-8. PubMed ID: 3986976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog.
    Darsee JR; Kloner RA; Braunwald E
    J Clin Invest; 1981 Jul; 68(1):225-39. PubMed ID: 7019244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function.
    Forman MB; Puett DW; Cates CU; McCroskey DE; Beckman JK; Greene HL; Virmani R
    Circulation; 1988 Jul; 78(1):202-13. PubMed ID: 3383404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes.
    Zhao ZQ; Nakamura M; Wang NP; Wilcox JN; Shearer S; Guyton RA; Vinten-Johansen J
    Coron Artery Dis; 1999 Dec; 10(8):617-28. PubMed ID: 10599541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.
    Litt MR; Jeremy RW; Weisman HF; Winkelstein JA; Becker LC
    Circulation; 1989 Dec; 80(6):1816-27. PubMed ID: 2598440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial thallium-201 kinetics and regional flow alterations with 3 hours of coronary occlusion and either rapid reperfusion through a totally patent vessel or slow reperfusion through a critical stenosis.
    Granato JE; Watson DD; Flanagan TL; Beller GA
    J Am Coll Cardiol; 1987 Jan; 9(1):109-18. PubMed ID: 3794089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
    Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
    J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration.
    Granato JE; Watson DD; Flanagan TL; Gascho JA; Beller GA
    Circulation; 1986 Jan; 73(1):150-60. PubMed ID: 3940665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion.
    Forman MB; Puett DW; Bingham SE; Virmani R; Tantengco MV; Light RT; Bajaj A; Price R; Friesinger G
    Circulation; 1987 Aug; 76(2):469-79. PubMed ID: 3608128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of residual stenosis on infarct size and regional transmural myocardial blood flow after reperfusion.
    Wilson JL; Ramanathan KB; Ingram LA; Mirvis DM
    Am Heart J; 1988 Dec; 116(6 Pt 1):1523-9. PubMed ID: 3195437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.